DIN 02528495 — GLN-ATOVAQUONE 750 MG
GLN-ATOVAQUONE is a suspension of Atovaquone marketed by GLENMARK PHARMACEUTICALS CANADA INC.. The full Atovaquone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02528495
- Brand name
- GLN-ATOVAQUONE
- Active ingredient
- Atovaquone
- Strength
- 750 MG
- Dosage form
- SUSPENSION
- Route
- ORAL
- Manufacturer
- GLENMARK PHARMACEUTICALS CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Antiprotozoal agent (hydroxynaphthoquinone)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Atovaquone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02556618 | AURO-ATOVAQUONE | 750 MG | SUSPENSION | AURO PHARMA INC | MARKETED |
| 02217422 | MEPRON | 750 MG | SUSPENSION | GLAXOSMITHKLINE INC | MARKETED |